Brief: Pharma Equity: Unit Reponex Receives USPTO Notice Of Allowance

Pharma Equity A/S

15/08/2023 12:57

Aug 15 (Reuters) - Pharma Equity Group A/S  PEGRP.CO :
    * REG-PHARMA EQUITY GROUP’S SUBSIDIARY COMPANY (REPONEX
PHARMACEUTICALS A/S) RECEIVES USPTO NOTICE OF ALLOWANCE FOR A
METHOD OF TREATMENT PATENT ON ITS TOPICAL WOUND-HEALING
COMPOSITION.
    * REPONEX PHARMACEUTICALS A/S (REPONEX) TODAY ANNOUNCED THAT
UNITED STATES PATENT AND TRADEMARK OFFICE (USPTO) HAS ISSUED A
NOTICE OF ALLOWANCE FOR US PATENT APPLICATION 16/366.898
    * A NOTICE OF ALLOWANCE INDICATES THAT USPTO INTENDS TO
GRANT
APPLICATION AFTER COMPLETION OF STANDARD PROCEDURAL STEPS
    * PATENT IS EXPECTED TO BE ISSUED WITHIN 1-2 MONTHS WITH
VALIDITY
UNTIL 2039

Source text for Eikon:  ID:nGNE3R470l 
Further company coverage:  PEGRP.CO 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))